Cargando…
ACPNet: A Deep Learning Network to Identify Anticancer Peptides by Hybrid Sequence Information
Cancer is one of the most dangerous threats to human health. One of the issues is drug resistance action, which leads to side effects after drug treatment. Numerous therapies have endeavored to relieve the drug resistance action. Recently, anticancer peptides could be a novel and promising anticance...
Autores principales: | Sun, Mingwei, Yang, Sen, Hu, Xuemei, Zhou, You |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8912097/ https://www.ncbi.nlm.nih.gov/pubmed/35268644 http://dx.doi.org/10.3390/molecules27051544 |
Ejemplares similares
-
A Novel Hybrid Sequence-Based Model for Identifying Anticancer Peptides
por: Xu, Lei, et al.
Publicado: (2018) -
Identifying anticancer peptides by using improved hybrid compositions
por: Li, Feng-Min, et al.
Publicado: (2016) -
ACP-BC: A Model for Accurate Identification of Anticancer Peptides Based on Fusion Features of Bidirectional Long Short-Term Memory and Chemically Derived Information
por: Sun, Mingwei, et al.
Publicado: (2023) -
LncCat: An ORF attention model to identify LncRNA based on ensemble learning strategy and fused sequence information
por: Feng, Hongqi, et al.
Publicado: (2023) -
iACP: a sequence-based tool for identifying anticancer peptides
por: Chen, Wei, et al.
Publicado: (2016)